skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

11 studies were found about vicriviroc

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00523211

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00474370

Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00551330

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00082498

Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)(TERMINATED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00243568

Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)

Condition: HIV Infections

NCT ID: NCT00632073

Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00686829

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)

Condition: HIV Infections

NCT ID: NCT00551018

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00766597

Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

Condition: HIV Infections

NCT ID: NCT00705419

Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM6)

Condition: HIV Infections

NCT ID: NCT00243230